Epilepsy; Seizure
21
4
4
10
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
9.5%
2 terminated out of 21 trials
83.3%
-3.2% vs benchmark
14%
3 trials in Phase 3/4
30%
3 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (21)
Sleep Spindles and Memory in Rolandic Epilepsy
Observational Study on Dynamic Changes of Blood Pressure During Post-epileptic Seizure Stage (OCBPS)
Thalamus Seizure Detection With a Deep Brain Stimulator System
Optimizing Brain Stimulation Parameters
Deep Brain Stimulation vs. Vagus Nerve Stimulation for Epileptic Spasms
North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2
An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
Genotype, Phenotype, and Disease Progression of Developmental Epileptic Encephalopathy With Onset Before 2 Years of Age
Forecasting Seizures Using Intelligent Wearable Technology for Health Tracking
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
Yoga and Aerobic Exercise in Epilepsy
Pharmacokinetics Study of Oral 2-Deoxy-D-Glucose (2DG) in Subjects With a Confirmed Diagnosis of Epilepsy
Earbud EEG Feasibility Study
The Prevalence and Risk Factors of Coagulopathy in Pediatric Epilepsy Surgery Patients
Seizures Detection in Real Life Setting
Clinical Validation of a Video-based Epilepsy Examination Service
ES-481 for Uncontrolled Glioma-Associated Epilepsy and Assessment for Potential Anti-Tumorigenic Effect in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Tumors
The Individual and Family Self Management Theory Based Epilepsy Education Program's Effectiveness
Generating Evidence on NonEpileptic, Stereotypical and Intermittent Symptoms (NESIS) in Chronic Subdural Hematomas
Impact of Self-visualization of Epileptic Seizures on Patients' Perception of the Disease and Risk Behavior